Lactobacillus crispatus LV5 88
- Reduced Chlamydia trachomatis Infectivity
- Increased Vaginal Colonization with Lactobacillus crispatus
- Reduced Sore Throat Severity
- Reduced Preterm Births
- Reduced Cytotoxicity
- Enhanced Antimicrobial Resistance
- Absence of Adverse Effects
- Reduced Candida albicans Colony-Forming Units
- Improved Immune Homeostasis
- Improved Symptoms of Bacterial Vaginosis